Home
Our Focus
Overview
Literature & Publications
Pipeline
Overview
Acute Ischemic Stroke
Cardio-Renal Disease
Clinical Trials
Overview
Acute Ischemic Stroke
ReMEDy2
Overview
About ReMEDy2
Stroke Disease
For Physicians
Trial Locations
About DiaMedica
Overview
Leadership
Careers
Contact
Investors Relations
Overview
Press Releases
Events & Presentations
Stock Data
Analyst Coverage
Financial Reports & SEC Filings
Governance
Resources
SEC Filings
Investors Relations
Investors Relations
Overview
Press Releases
Events & Presentations
Stock Data
Nasdaq Quote
Charts
Historical Data
Analyst Coverage
Financial Reports & SEC Filings
SEC Filings
Annual Reports
Tax Information (PFIC)
Governance
Board of Directors
Board Committees
Governance Documents
Resources
Investor Contact
FAQ
Share Consolidation Instructions
Email Alerts
Financial Reports & SEC Filings
SEC Filings
Annual Reports
Tax Information (PFIC)
Filing Type:
View All
10-K
10-K/A
10-Q
20FR12B
20FR12B/A
3
4
424B3
424B4
424B5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
REGDEX
RW
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2023
2022
2021
2020
2019
2018
2014
2007
Date
Form
Description
PDF
XBRL
Pages
09/17/18
DRS/A
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Documents
EX-10.5
EX-10.6
169
09/04/18
UPLOAD
SEC-generated letter
Documents
TEXT-EXTRACT
2
08/27/18
DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Documents
EX-3.1
EX-3.2
EX-3.4
EX-4.1
EX-4.2
EX-4.3
EX-4.4
EX-4.5
EX-4.6
EX-4.7
EX-4.8
EX-4.9
EX-4.10
EX-4.11
EX-4.12
EX-4.13
EX-4.14
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-10.7
EX-10.8
EX-10.9
EX-10.10
EX-21.1
486
04/17/18
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
6
04/03/18
RW
Registration Withdrawal Request
2
03/11/14
20FR12B/A
Form for initial registration of a class of securities of foreign private issuers pursuant to section 12(b)
Documents
EX-4.6
EX-4.7
EX-15.1
215
01/30/14
20FR12B
Form for initial registration of a class of securities of foreign private issuers pursuant to section 12(b)
Documents
EX-1.1
EX-1.2
EX-1.3
EX-1.4
EX-1.5
EX-2.1
EX-4.1
EX-4.2
EX-4.3
EX-4.4
EX-4.5
EX-8.1
240
05/16/07
REGDEX
Notice of Sale of Securities [Regulation D and Section 4(6) of the Securities Act of 1933]
9
Previous
1…
20
21
22
23
24
25
26
27
28
29
Email Alerts
Contacts
RSS News Feed